Install
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
- 913articles · 365d
- 3+ hour agolatest article
- Sep 14, 2025earliest in window
- 95%with images
- 285avg words
- Medical 573
- Business & Industrial 538
- Economy, Business & Finance 451
- Health & Wellness 337
- Health 267
- Finance & Business 254
- Science & Technology 156
- Science & Nature 42
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
What Steps US Regulators Are Taking to Promote Domestic Investment
1+ mon, 1+ week ago (228+ words) John Stanford, executive director at Incubate, explains the COINS Act debate: should Treasury restrict US biotech investment in China, and what happens to American leadership if it does. Earlier this year, a report from Pharmaceutical Executive detailed the ways in…...
The Gates Foundation: Perfectly Aligned Interests
3+ mon, 4+ week ago (125+ words) Pharmaceutical Executive Toragen’s partnership with the Bill & Melinda Gates Foundation highlights how global health priorities and commercial biotech strategy can align around one of the world’s deadliest HPV-driven cancers. In the third part of her interview with Pharmaceutical Executive, Sandra…...
Building Operational Visibility in Clinical Trials: Q&A with Deepak Prakash
4+ mon, 4+ week ago (931+ words) Identiv’s VP of healthcare discusses the impact of new technology and data collection on trial design. New technology provides members of the industry with the ability to collect and sort data at a significantly higher scale than ever before. While…...
What an End-to-End Model Changes for Patients
5+ mon, 2+ week ago (326+ words) Pharmaceutical Executive Charles DeYoung, Director of Patient Support Operations at Caretria, discusses how CareTria is reshaping patient support in a complex healthcare environment. In a conversation with Pharmaceutical Executive DeYoung explains that an end-to-end patient support model is designed to…...
Navigating Complexity in Emerging Biotech: Innovations, Integrations, and Initial Hurdles
6+ mon, 16+ hour ago (882+ words) Industry experts across the biotech sector discuss the latest trends impacting emerging biotech companies, including the challenges of early-stage biotech start-ups, AI integration across the sector, and the most recent innovations in drug discovery. Emerging Pharma Leaders nominations are now…...
Addressing Key Barriers for Women in STEM | PharmExec
7+ mon, 1+ day ago (559+ words) Addressing Key Barriers for Women in STEM Pharmaceutical Executive Kim Boericke, CEO, Veristat, discussed her new role and the company's focus on data analytics, automation, and early-stage strategic consulting. In a conversation with Pharmaceutical Executive,she highlighted the importance of…...
Rethinking Tail Spend: Transforming Procurement Before Compliance Risks Escalate | PharmExec
7+ mon, 2+ week ago (707+ words) Taking a more strategic, data-driven approach to tail spend can transform procurement from a fragmented cost center into a source of compliance strength, operational efficiency, and greater supply chain confidence. Pharmaceutical and life sciences organizations operate under extraordinary regulatory pressure....
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat | PharmExec
7+ mon, 2+ week ago (388+ words) Poor visualization techniques can oversimplify reality and make data less potent. Sunitha Venkat, vice president of data services and insights at Conexus Solutions, spoke with Pharmaceutical Executive about the importance of using high quality data visualization methods. According to her,…...
GCC Emerges as a New Strategic Anchor for Global Venture Capital | PharmExec
10+ mon, 1+ week ago (324+ words) Five key takeaways from the Future Investment Initiative panel on the Gulf region’s growing role in global VC. The panel examined the forces reshaping the global flow of venture capital, from sovereign wealth participation and regulatory reform to family office…...